Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis
- PMID: 18986848
- DOI: 10.1016/j.cgh.2008.08.012
Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis
Abstract
Background & aims: Weight loss in overweight or obese individuals results in marked improvement or resolution of hypertension, diabetes mellitus, and hyperlipidemia. However, the overall effect of weight loss on nonalcoholic fatty liver disease (NAFLD) remains unclear. This systematic review and meta-analysis is an effort to explore the effect of weight loss after bariatric surgical procedures on NAFLD.
Methods: We performed an electronic literature search of published articles on bariatric surgery and liver histology since inception to September of 2007. Primary outcome measures were improvement and/or resolution in the 3 components of NAFLD (steatosis, steatohepatitis, and fibrosis) after bariatric surgery-induced weight loss. A pooled proportion of patients with improvement or resolution was calculated for steatosis, steatohepatitis, and fibrosis using a random effects model. Heterogeneity among the studies was assessed using the I(2) (inconsistency) statistic and subgroup analyses.
Results: A total of 15 studies (766 paired liver biopsies) were selected for final data extraction. The percentage reduction in mean body mass index after bariatric surgeries ranged from 19.11 to 41.76. The pooled proportion of patients with improvement or resolution in steatosis was 91.6% (95% confidence interval [CI], 82.4%-97.6%), in steatohepatitis was 81.3% (95% CI, 61.9%-94.9%), in fibrosis was 65.5% (95% CI, 38.2%-88.1%), and for complete resolution of nonalcoholic steatohepatitis was 69.5 (95% CI, 42.4%-90.8%).
Conclusions: Steatosis, steatohepatitis, and fibrosis appear to improve or completely resolve in the majority of patients after bariatric surgery-induced weight loss.
Similar articles
-
Utility of transient elastography (fibroscan) and impact of bariatric surgery on nonalcoholic fatty liver disease (NAFLD) in morbidly obese patients.Surg Obes Relat Dis. 2018 Jan;14(1):81-91. doi: 10.1016/j.soard.2017.09.005. Epub 2017 Sep 11. Surg Obes Relat Dis. 2018. PMID: 29126863
-
Bariatric surgery improves nonalcoholic fatty liver disease: a contemporary systematic review and meta-analysis.Surg Obes Relat Dis. 2019 Mar;15(3):502-511. doi: 10.1016/j.soard.2018.12.002. Epub 2018 Dec 6. Surg Obes Relat Dis. 2019. PMID: 30683512
-
Laparoscopic bariatric surgery: what else are we uncovering? Liver pathology and preoperative indicators of advanced liver disease in morbidly obese patients.Surg Endosc. 2007 Nov;21(11):1957-60. doi: 10.1007/s00464-007-9351-4. Epub 2007 May 4. Surg Endosc. 2007. PMID: 17479322
-
The impact of bariatric surgery on nonalcoholic steatohepatitis.Semin Liver Dis. 2012 Feb;32(1):80-91. doi: 10.1055/s-0032-1306428. Epub 2012 Mar 13. Semin Liver Dis. 2012. PMID: 22418890 Review.
-
The role of bariatric surgery in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.Expert Rev Gastroenterol Hepatol. 2017 Sep;11(9):797-811. doi: 10.1080/17474124.2017.1355731. Epub 2017 Jul 21. Expert Rev Gastroenterol Hepatol. 2017. PMID: 28712339 Review.
Cited by
-
Current treatment options for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.Can J Gastroenterol. 2012 Jun;26(6):353-7. doi: 10.1155/2012/725468. Can J Gastroenterol. 2012. PMID: 22720278 Free PMC article. Review.
-
Impact of gastric bypass surgery on the liver fibrosis of patients with extreme obesity and nonalcoholic fatty liver disease in 30-month follow-up.Updates Surg. 2023 Apr;75(3):659-669. doi: 10.1007/s13304-022-01421-3. Epub 2022 Dec 19. Updates Surg. 2023. PMID: 36529770
-
Glucagon-like peptide-1 receptor is present on human hepatocytes and has a direct role in decreasing hepatic steatosis in vitro by modulating elements of the insulin signaling pathway.Hepatology. 2010 May;51(5):1584-92. doi: 10.1002/hep.23569. Hepatology. 2010. PMID: 20225248 Free PMC article.
-
Non-Alcoholic Fatty Liver Disease (NAFLD) and Bariatric/Metabolic Surgery as Its Treatment Option: A Review.J Clin Med. 2021 Dec 7;10(24):5721. doi: 10.3390/jcm10245721. J Clin Med. 2021. PMID: 34945016 Free PMC article. Review.
-
A Structured Literature Review of the Epidemiology and Disease Burden of Non-Alcoholic Steatohepatitis (NASH).Adv Ther. 2019 Jul;36(7):1574-1594. doi: 10.1007/s12325-019-00960-3. Epub 2019 May 7. Adv Ther. 2019. PMID: 31065991 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical